During the past decade, St James's University Hospital - Haematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St James's University Hospital - Haematology" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Celgene" with 1 trials sponsored, "Celgene Corporation" with 1 trials sponsored, "Cephalon" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "St James's University Hospital - Haematology" are "Multiple Myeloma" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Hepatocellular Carcinoma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "St James's University Hospital - Haematology" in a lesser frequency.

Most popular intervention types in "St James's University Hospital - Haematology" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "CC-5013" (1 trials), "Chlorambucil" (1 trials), "R-etodolac + chlorambucil" (1 trials) and "bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "St James's University Hospital - Haematology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "St James's University Hospital - Haematology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in St James's University Hospital - Haematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St James's University Hospital - Haematology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".